When less is more: how many doses of PCV are enough?

Slides:



Advertisements
Similar presentations
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Advertisements

Food systems, nutrition, health and the environment
Authorship trends in The Lancet Global Health
The commercial determinants of health
COPD and asthma: the emergency is clear, now is the time for action
Helen Cox, Mark P Nicol  The Lancet Infectious Diseases 
Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study  Dr.
Author gender in The Lancet journals
COPD and asthma: the emergency is clear, now is the time for action
The impact of megacities on health: preparing for a resilient future
Underestimate of annual malaria imports to Canada – Author reply
Brandon A Kohrt, Suzan J Song  The Lancet Global Health 
Charity begins at home in global health research funding
Threats to human health by great ocean garbage patches
Household energy and health: where next for research and practice?
Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants:
Do air quality alerts benefit public health? New evidence from Canada
Gender myths in global health
Nicola Low, Joost H Smid  The Lancet Public Health 
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:
Effective cross-sector collaborations create sustainability
Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis  Dr Tinevimbo.
Arnaud Chiolero  The Lancet Public Health 
Jonathan Broad, Matthew D Snape  The Lancet Public Health 
Anthony Rodgers, Alistair Woodward, Boyd Swinburn, William H Dietz 
Malebona Precious Matsoso, Jeanette Rebecca Hunter, Vishal Brijlal 
Effect of development assistance on domestic health expenditures
Food systems, nutrition, health and the environment
Mapping university global health partnerships
Sherif M Abdalla, Robert Bortolussi, Noni E MacDonald 
What would happen if we stopped vaccination?
Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach?  Stefanie Desmet, Jan Verhaegen, Marc Van Ranst,
Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis  Cynthia Chen, PhD, Francisco Cervero Liceras, MSc, Stefan.
Democratic reform and health: interpreting causal estimates
Authorship trends in The Lancet Global Health
Risk of poor development in young children in low-income and middle-income countries: an estimation and analysis at the global, regional, and country.
Volume 393, Issue 10172, Pages (February 2019)
Effect of pneumococcal conjugate vaccine introduction on childhood pneumonia mortality in Brazil: a retrospective observational study  Cynthia Schuck-Paim,
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort.
Elder abuse prevalence in community settings: a systematic review and meta-analysis  Yongjie Yon, MA, Christopher R Mikton, PhD, Zachary D Gassoumis, PhD,
Sufang Guo, Nuzhat Rafique, Danzhen You, Douglas J Noble 
Forecasting the care needs of the older population in England over the next 20 years: estimates from the Population Ageing and Care Simulation (PACSim)
Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national.
Muh Geot Wong, Vlado Perkovic  The Lancet Diabetes & Endocrinology 
Thank you to our diverse (but not diverse enough) reviewers
Capacity building in sub-Saharan Africa: models of care
Volume 392, Issue 10160, Pages (November 2018)
Kathleen M Neuzil, Karen L Kotloff  The Lancet Global Health 
Artefenomel: a promising new antimalarial drug
Volume 6, Issue 3, Pages (March 2019)
Matthieu J Guitton  The Lancet Planetary Health 
Spatial lifecourse epidemiology
Buyun Liu, Yangbo Sun, Wei Bao  The Lancet Planetary Health 
How concentrated are academic publications of countries' progression towards universal health coverage?  Adrian Gheorghe, Kalipso Chalkidou, Anthony Culyer 
Reducing the global burden of preterm births
Malaria innovations: pursuing value in an evolving market
Restructuring physical micro-environments to reduce the demand for meat: a systematic review and qualitative comparative analysis  Filippo Bianchi, MPhil,
Jean H Humphrey, Andrew J Prendergast  The Lancet Global Health 
Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya  John Ojal, PhD, Ulla Griffiths,
Reducing the cardiovascular disease burden for people of all ages in the Americas region: analysis of mortality data, 2000–15  Prof Peter Lloyd-Sherlock,
Improving management of neonatal infections
Jeffrey T Howard, Alexis R Santos-Lozada  The Lancet Planetary Health 
Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi- eligible countries: a modelling study  Joke Bilcke, PhD, Marina.
Deriving a practical framework for the evaluation of health apps
Refining treatment choices for ADHD
Peng Jia, Youfa Wang  The Lancet Global Health 
Institutional challenges to achieving health equity in Ecuador
Connecting planetary health, climate change, and migration
Sickle cell disease: a new era
Practical guidance on artificial intelligence for health-care data
Presentation transcript:

When less is more: how many doses of PCV are enough? Katherine L O'Brien  The Lancet Infectious Diseases  Volume 18, Issue 2, Pages 127-128 (February 2018) DOI: 10.1016/S1473-3099(17)30684-9 Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

Figure Countries that have introduced pneumococcal conjugate vaccine into their routine immunisation programme PCV=pneumococcal conjugate vaccine. NIP=national immunisation programme. Figure reproduced with permission from VIEW-Hub.org on Nov 10, 2017. The Lancet Infectious Diseases 2018 18, 127-128DOI: (10.1016/S1473-3099(17)30684-9) Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.